MoonLake Immunotherapeutics (MLTX) Other Non Operating Income (2021 - 2026)

MoonLake Immunotherapeutics' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 54.8% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $18.5 million (down 20.72% YoY), while the FY2025 annual figure was $22.4 million, up 1.1% from the prior year.
• Other Non Operating Income was $3.2 million for Q1 2026 at MoonLake Immunotherapeutics, down from $4.4 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $7.2 million in Q4 2023 to a low of $37593.0 in Q3 2022.
• Historically, Other Non Operating Income has averaged $3.4 million across 5 years, with a median of $3.2 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Other Non Operating Income soared 6584.92% in 2022, then plunged 55.1% in 2024.
• A 5-year view of Other Non Operating Income shows it stood at $239505.0 in 2022, then soared by 2900.12% to $7.2 million in 2023, then slumped by 55.1% to $3.2 million in 2024, then soared by 37.69% to $4.4 million in 2025, then dropped by 27.78% to $3.2 million in 2026.
• The last three Other Non Operating Income figures came in at $3.2 million (Q1 2026), $4.4 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.